GlassScriptPhysician profile
Ming-Wai Selig
NPI 1710562988
$1,171.47
in general payments reported to CMS, 2019-2025
12 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.21 · 2022: $68.33 · 2024: $358 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.17 |
| Education | $136.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $497.82 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $186.36 | 2025 | Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $91.67 | 2024-2025 | Invega Sustenna |
| Abbvie INC. | $74.51 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $71.90 | 2025 | Fanapt |
| Ultragenyx Pharmaceutical INC. | $68.33 | 2022 | |
| Neurocrine Biosciences, INC. | $63.36 | 2024-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $47.99 | 2025 | Abilify Maintena, Abilify Asimtufii |
| Alkermes, INC. | $26.66 | 2025 | Aristada, Lybalvi |
| Lilly USA, LLC | $17.30 | 2021 | |
| Indivior INC. | $15.66 | 2024 | Perseris |
| Genentech USA, INC. | $9.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming-Wai Selig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.